Luigi Ferrucci

Luigi Ferrucci serves as Scientific Director of the National Institute on Aging (NIA) and Chief of the Longitudinal Studies Section, directing the Baltimore Longitudinal Study on Aging (BLSA) at the NIH campus in Baltimore, Maryland. His leadership spans critical aging research infrastructure and national scientific strategy.

Dr. Ferrucci earned his Medical Degree (1980), Geriatrics Board Certification (1982), and Ph.D. in Biology and Pathophysiology of Aging (1998) from the University of Florence, Italy. His academic foundation includes appointments as Associate Professor of Biology, Human Physiology, and Statistics at the same institution.

His pioneering research investigates frailty as a biological state driving global disease susceptibility in aging, challenging stochastic models of comorbidity. Through longitudinal frameworks like the BLSA and InCHIANTI study, he examines causal pathways for physical/cognitive decline, mobility disability, and neurodegeneration. His work integrates multi-omics approaches to identify biomarkers of biological aging and resilience.

Recent publications (2017-2025) reveal three dominant trajectories: neurodegeneration patterns linking gait/memory decline (2025), sex-specific biomarker dynamics in Alzheimer's progression (2025), and mitochondrial-muscle physiology underpinning functional decline (2017-2018). The 2024 biomarker validation study establishes methodological standards for geroscience.

No scientific awards were explicitly referenced in source materials.

As Principal Investigator of the InCHIANTI study and BLSA Director, Dr. Ferrucci leads large-scale epidemiological projects across six continents. His mentorship spans junior investigators in the NIA intramural program, though specific advisees aren't listed. Research funding supports the BLSA's expansion into normal aging mechanisms and pre-frailty phenotypes.

The Longitudinal Studies Section operates the BLSA—the world's longest-running scientific study of aging—using advanced imaging, omics, and functional assessments. Current initiatives focus on refining frailty metrics and identifying early intervention targets to compress morbidity in aging populations.